Huntsman (HUN) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Huntsman (HUN) reported Q2 revenue of $1.46 billion, a 7.4% year-over-year decline and a 1.26% miss against the Zacks Consensus Estimate. The company posted an EPS of -$0.20, down from $0.14 year-over-year and a 33.33% negative surprise against the -$0.15 consensus. Key segment revenues, including Polyurethanes, Advanced Materials, and Performance Products, also declined year-over-year and generally fell short of analyst expectations, driven by lower sales volumes. This underperformance has resulted in Huntsman shares returning -12.5% over the past month, significantly lagging the S&P 500's +2.7% gain, and the stock carries a Zacks Rank #5 (Strong Sell) indicating potential near-term underperformance.

Analysis

Huntsman Corporation reported a weak second quarter, missing analyst consensus on both top and bottom lines. Revenue came in at $1.46 billion, a 7.4% year-over-year decline and a 1.26% miss against estimates, while the reported EPS of -$0.20 represented a stark reversal from the $0.14 profit in the prior-year quarter and a significant -33.33% negative surprise versus the consensus estimate of -$0.15. The underperformance was broad-based, with all key business segments—Polyurethanes, Performance Products, and Advanced Materials—posting year-over-year revenue declines and falling short of Wall Street's projections. The weakness appears driven by deteriorating demand, evidenced by sales volume declines that were worse than anticipated in both the Performance Products segment (-9% vs. -3.3% estimated) and the Advanced Materials segment (-3% vs. -0.2% estimated). This poor operational result has been reflected in the market, with HUN's shares returning -12.5% over the past month, a stark contrast to the S&P 500's +2.7% gain, and the stock's current Zacks Rank #5 (Strong Sell) underscores a bearish near-term outlook.

Key Decisions for Investors

• Investors should re-evaluate long positions in Huntsman given the significant Q2 earnings and revenue miss, which points to deteriorating fundamental performance across all key segments.
• The stock's sharp -12.5% underperformance against the broader market in the last month, combined with a 'Strong Sell' rating from Zacks, indicates significant negative momentum and suggests further downside risk.
• Pay close attention to forward-looking management guidance on demand and sales volumes, as the unexpected severity of volume declines, particularly in Performance Products, is a critical red flag for the company's near-term operating environment.